Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part -III

Athina       Geronikaki

doi:10.2174/156802662104210216114559

[1] 
Tratrat, C.; Haroun, M.; Tsolaki, E.; Petrou, A.; Gavalas, A.; Geronikaki, A. Thiazole-based chalcone derivatives as potential anti-inflammatory agents: biological evaluation and molecular modelling. Curr. Top. Med. Chem.,  2021, 21(4), 257-268.
[2] 
Bhunia, S.S.; Saxena, A.K. Efficiency of homology modeling assisted molecular docking in g-protein coupled receptors. Curr. Top. Med. Chem.,  2021, 21(4), 269-294.
[3] 
Venugopala, K.N.; Tratrat, C.; Deb, P.K.; Pillay, M.; Chopra, D.; Chandrashekharappa, S.; Haroun, M.; Morsy, M.A.; Aldhubiab, B.E.; Attimarad, M.; Nair, A.B.; Sreeharsha, N.; Kandeel, M.; Venugopala, R.; Mohanlall, V. 4-aryl-1,4-dihydropyridines as potential enoyl-acyl carrier protein reductase inhibitors: antitubercular activity and molecular docking study. Curr. Top. Med. Chem.,  2021, 21(4), 295-306.
[4] 
Sharma, A.; Kaliya, K.; Maurya, S.K. Recent advances in the discovery of potent proteases inhibitors targeting the SARS coronaviruses. Curr. Top. Med. Chem.,  2021, 21(4), 307-328.

Rights & Permissions Print Cite

Article Metrics

4

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/156802662104210216114559	Print ISSN 1568-0266
Publisher Name Bentham Science Publisher	Online ISSN 1873-4294

Current Topics in Medicinal Chemistry

Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part -III

Related Journals

Related Books